Eric H Raabe Selected Research

Eric H Raabe Research Topics

Disease

31	Neoplasms (Cancer) 04/2022 - 06/2011
14	Glioma (Gliomas) 01/2021 - 07/2013
9	Diffuse Intrinsic Pontine Glioma 01/2020 - 01/2014
8	Brain Neoplasms (Brain Tumor) 01/2020 - 01/2014
7	Medulloblastoma 03/2022 - 01/2016
7	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 10/2012
5	Rhabdoid Tumor (Rhabdoid Tumors) 04/2022 - 02/2015
3	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2020 - 10/2018
2	Astrocytoma (Pilocytic Astrocytoma) 12/2013 - 06/2011
1	Hepatoblastoma 01/2021
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Neurofibroma 10/2018
1	Neurofibrosarcoma (MPNST) 10/2018
1	Nerve Sheath Neoplasms (Nerve Sheath Neoplasm) 10/2018
1	Plexiform Neurofibroma 10/2018
1	Typical Teratoid Rhabdoid Tumor 01/2017
1	Primitive Neuroectodermal Tumors (PNET) 01/2017
1	Hypoxia (Hypoxemia) 11/2015
1	Carcinogenesis 02/2015
1	Neurofibromatoses (Neurofibromatosis) 12/2013

Drug/Important Bio-Agent (IBA)

8	dipinacoline glutamateIBA 01/2020 - 01/2014
7	Mechanistic Target of Rapamycin Complex 1IBA 04/2022 - 12/2013
7	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2013
5	Phosphotransferases (Kinase)IBA 01/2021 - 02/2015
4	Glutamine (L-Glutamine)FDA Link 03/2022 - 10/2019
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 02/2015
4	TOR Serine-Threonine KinasesIBA 01/2021 - 12/2013
4	Mitogen-Activated Protein KinasesIBA 01/2021 - 12/2013
4	Histones (Histone)IBA 01/2020 - 06/2014
3	Glutathione (Reduced Glutathione)IBA 03/2022 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 10/2017
3	Messenger RNA (mRNA)IBA 01/2021 - 10/2012
2	sapanisertibIBA 04/2022 - 03/2016
2	Glutamic Acid (Glutamate)FDA Link 03/2022 - 03/2016
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 10/2017
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 01/2019
2	trametinibIBA 01/2021 - 01/2020
2	ProdrugsIBA 01/2021 - 10/2019
2	MitogensIBA 01/2020 - 02/2015
2	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2012
2	5-hydroxymethylcytosineIBA 10/2018 - 06/2014
2	Transcription Factors (Transcription Factor)IBA 01/2017 - 11/2015
2	MicroRNAs (MicroRNA)IBA 02/2015 - 07/2013
2	ChromatinIBA 02/2015 - 07/2013
1	obatoclaxIBA 04/2022
1	Amino Acids FDA Link 03/2022
1	Tricarboxylic AcidsIBA 03/2022
1	Glucose (Dextrose)FDA LinkGeneric 03/2022
1	NucleotidesIBA 03/2022
1	CarbonIBA 03/2022
1	HexosaminesIBA 03/2022
1	Ethiodized Oil (Ethiodol)FDA Link 01/2021
1	JHU395IBA 01/2021
1	PlatinumIBA 01/2021
1	Focal Adhesion Protein-Tyrosine KinasesIBA 01/2020
1	binimetinibIBA 01/2020
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2020
1	Drug CombinationsIBA 11/2019
1	DiazooxonorleucineIBA 10/2019
1	MethyltransferasesIBA 04/2019
1	Everolimus FDA Link 01/2019
1	1- (6- (3,5- dichloro- 4- hydroxyphenyl)- 4- ((4- ((dimethylamino)methyl)cyclohexyl)amino)- 1,5- naphthyridin- 3- yl)ethanoneIBA 11/2018
1	Polycomb Repressive Complex 2IBA 10/2018
1	CytokinesIBA 04/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2018
1	magrolimabIBA 01/2017
1	AntibodiesIBA 01/2017
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 03/2016
1	GlutaminaseIBA 03/2016
1	compound 968IBA 03/2016
1	Temozolomide (Temodar)FDA LinkGeneric 03/2016
1	LGK974IBA 03/2016
1	MRK 003IBA 03/2016
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2016
1	palbociclibIBA 01/2016
1	Digoxin (Digitek)FDA LinkGeneric 11/2015
1	Oxygen (Dioxygen)IBA 11/2015
1	AZD 6244IBA 02/2015
1	Lysine (L-Lysine)FDA Link 06/2014
1	5-Methylcytosine (5 Methylcytosine)IBA 06/2014
1	Mechanistic Target of Rapamycin Complex 2IBA 12/2013
1	ridaforolimusIBA 12/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 06/2011
1	GalactosidasesIBA 06/2011

Therapy/Procedure

8	Therapeutics 04/2022 - 10/2016
3	Drug Therapy (Chemotherapy) 01/2021 - 10/2017
1	Precision Medicine 09/2017
1	Heterologous Transplantation (Xenotransplantation) 09/2017
1	Immunotherapy 09/2017
1	Investigational Therapies (Experimental Therapy) 01/2016